{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Novartis A.G. of Switzerland said yesterday that it would offer cards to low-income elderly Americans to provide discounts of 25 percent or more on the company's brand-name drugs. Novartis said the discounts would take effect in January. Those eligible will be people who are 65 or older and have incomes of $26,000 or less for single people and $35,000 for couples.", "headline": {"main": "Novartis Plans Drug Discount For Elderly"}, "abstract": "Novartis AG, Swiss drug manufacturer, will offer cards to low-income elderly Americans to provide discounts of 25 percent or more, beginning in January 2002, on company's brand-name drugs; those eligible would be people 65 or older, with incomes of $26,000 or less for single people and $35,000 for couples (M)", "print_page": "4", "word_count": 472, "_id": "4fd229888eb7c8105d7b3207", "snippet": "Novartis A.G. of Switzerland said yesterday that it would offer cards to low-income elderly Americans to provide discounts of 25 percent or more on the company's brand-name drugs.    Novartis said the discounts would take effect in January. Those...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/11/08/business/novartis-plans-drug-discount-for-elderly.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "NOVARTIS AG"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "2001-11-08T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 31, "offset": 30, "time": 34}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}